A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release

Giovanni Di Nardo1, Salvatore Oliva, Marina Aloi

  • 1Department of Pediatrics, Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, 00161 Rome, Italy.

Insights

Pediatric Menetrier

Area of Science:

  • Pediatric Gastroenterology
  • Gastrointestinal Pathology

Background:

  • Menetrier's disease (MD) is a rare hypertrophic gastropathy in children, often self-limiting.
  • It involves enlarged gastric folds, epithelial hyperplasia, and protein-losing gastropathy.

Observation:

  • A case of non self-limited pediatric MD required endoscopic mucosal resection for diagnosis.
  • This patient had previously undergone conventional endoscopic biopsy without definitive findings.

Findings:

  • The pediatric MD case was successfully treated with octreotide long-acting release (LAR).
  • This represents the first reported pediatric MD case managed with octreotide LAR.

Implications:

  • Octreotide LAR may be a viable treatment for refractory pediatric MD, potentially avoiding gastrectomy.
  • This suggests a new therapeutic avenue for challenging MD cases.